Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas

Claudio Tripodo, Enrico Derenzini, Sabino Ciavarella, Saveria Mazzara, Valentina Tabanelli, Maria Carmela Vegliante, Stefano A. Pileri, Federica Melle, Stefano Fiori, Stefano Fiori, Stefano A. Pileri, Claudio Tripodo, Giovanna Motta

Risultato della ricerca: Articlepeer review

4 Citazioni (Scopus)


Diffuse large B-cell lymphoma (DLBCL) is the commonest form of lymphoid malignancy, with a prevalence of about 40% worldwide. Its classification encompasses a common form, also termed as "not otherwise specified" (NOS), and a series of variants, which are rare and at least in part related to viral agents. Over the last two decades, DLBCL-NOS, which accounts for more than 80% of the neoplasms included in the DLBCL chapter, has been the object of an increasing number of molecular studies which have led to the identification of prognostic/predictive factors that are increasingly entering daily practice. In this review, the main achievements obtained by gene expression profiling (with respect to both neoplastic cells and the microenvironment) and next-generation sequencing will be discussed and compared. Only the amalgamation of molecular attributes will lead to the achievement of the long-term goal of using tailored therapies and possibly chemotherapy-free protocols capable of curing most (if not all) patients with minimal or no toxic effects.
Lingua originaleEnglish
pagine (da-a)675-
Numero di pagine15
Stato di pubblicazionePublished - 2021

All Science Journal Classification (ASJC) codes

  • ???subjectarea.asjc.2700.2700???


Entra nei temi di ricerca di 'Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas'. Insieme formano una fingerprint unica.

Cita questo